Omadacycline for stubborn mycoplasma genitalium infections
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new antibiotic, omadacycline, for men with a persistent urethral infection caused by mycoplasma genitalium that hasn't cleared with standard treatments. If you've completed the usual two-step antibiotic course and still have symptoms, this study might offer another option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have symptoms like pain or burning when urinating, discomfort, or discharge from the urethra.
- Tests show you have mycoplasma genitalium, but no chlamydia, gonorrhea, or trichomonas.
- Your infection hasn't cleared at least 21 days after finishing standard treatment (doxycycline then moxifloxacin).
- You are not pregnant or breastfeeding, and you don't have severe liver problems or an allergy to omadacycline.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests the antibiotic tinidazole for treating Mycoplasma genitalium infection in people with urethritis (inflammation of the urine tube). It aims to see how well the drug clears the infection and improves sexual health.
This trial tests whether omadacycline (an antibiotic) can safely and effectively treat a rare lung infection caused by Mycobacterium abscessus bacteria. If you have this infection, this study may help doctors understand if this antibiotic works better than current treatments.
This trial tests a combination of three medicines (doxycycline, pentoxifylline, and nitazoxanide) to treat gonorrhea and chlamydia in men. The goal is to see if this combination works better than standard treatment.
This trial tests whether taking doxycycline can lower the chance of getting bacterial sexually transmitted infections like syphilis, gonorrhea, and chlamydia. It is aimed at men who have had these infections recently and expect to keep having multiple male partners.
This trial tests whether taking a single dose of doxycycline after sex can prevent common sexually transmitted infections (STIs) like gonorrhea, chlamydia, and syphilis in men who have sex with men (MSM) in Bangkok.
This trial compares a longer, higher-dose antibiotic course combined with methenamine hippurate (a urinary antiseptic) against standard care (low-dose antibiotics or methenamine alone) for women with chronic urinary tract infections. It aims to see if the extended treatment is more effective at relieving persistent symptoms.
Hear when a new Mycoplasma Genitalium Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.